Commonwealth Equity Services’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30K | Hold |
18,298
| – | – | ﹤0.01% | 4201 |
|
|
2025
Q1 | $29K | Hold |
18,298
| – | – | ﹤0.01% | 4107 |
|
|
2024
Q4 | $61K | Hold |
18,298
| – | – | ﹤0.01% | 3969 |
|
|
2024
Q3 | $34K | Buy |
+18,298
| New | +$34K | ﹤0.01% | 3966 |
|
|
2022
Q1 | – | Sell |
-1,106
| Closed | -$20K | – | 3809 |
|
|
2021
Q4 | $20K | Hold |
1,106
| – | – | ﹤0.01% | 3601 |
|
|
2021
Q3 | $27K | Buy |
1,106
+68
| +7% | +$1.66K | ﹤0.01% | 3535 |
|
|
2021
Q2 | $65K | Hold |
1,038
| – | – | ﹤0.01% | 3443 |
|
|
2021
Q1 | $127K | Sell |
1,038
-34
| -3% | -$4.16K | ﹤0.01% | 3233 |
|
|
2020
Q4 | $122K | Sell |
1,072
-371
| -26% | -$42.2K | ﹤0.01% | 3033 |
|
|
2020
Q3 | $172K | Hold |
1,443
| – | – | ﹤0.01% | 2774 |
|
|
2020
Q2 | $179K | Buy |
1,443
+66
| +5% | +$8.19K | ﹤0.01% | 2643 |
|
|
2020
Q1 | $265K | Buy |
1,377
+29
| +2% | +$5.58K | ﹤0.01% | 2156 |
|
|
2019
Q4 | $450K | Buy |
+1,348
| New | +$450K | ﹤0.01% | 2000 |
|